Bundamedik Tbk vs Tigaraksa Satria Tbk. — how do they compare? Bundamedik Tbk trades at Rp189 (market cap 1.62T, 222.6K 24h volume), while Tigaraksa Satria Tbk. trades at Rp5,000 (market cap 4.57T, 1.3K 24h volume). The key difference: Tigaraksa Satria Tbk. is far larger — about 2.8× Bundamedik Tbk's market cap, and Bundamedik Tbk is more actively traded (222.6K versus 1.3K). Which is the better fit depends on your goals.
| BMHS | TGKA | |
|---|---|---|
Market Cap | 1.62T | 4.57T |
Volume | 222.6K | 1.3K |
Lot | 2.23K | 13 |
Turnover | 42.02M | 6.7M |
Average Price | 188.79 | 5,151.15 |
Value | 42.02M | 6.7M |
Indicative Equilibrium Price | 189 | — |
Indicative Equilibrium Volume | 100 | — |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Tigaraksa Satria Tbk (the Company) was established in Jakarta based on notarial deed No. 35 of M.M.I. Wiardi, S.H., dated November 17, 1986. PT. Tigaraksa Satria is a distributor of Nutrition, Chemicals, Cosmetic, Books, Garments and other consumer goods. Founded in 1987 as a subsidiary of PT. Tigaraksa, the company handles the dosmetic distribution products for more than 20 pricipals.
Read more on TGKA →